behalf of the RENEW Study Group, Hartman, J. E., Shah, P. L., Sciurba, F., Herth, F. J. F., & Slebos, D-J. (2020). Endobronchial coils for emphysema: Dual mechanism of action on lobar residual volume reduction. Respirology, 25(11), 1160-1166. https://doi.org/10.1111/resp.13816

Pouwels, S. D., Wiersma, V. R., Fokkema, I. E., Berg, M., Ten Hacken, N. H. T., Van Den Berge, M., Heijink, I., & Faiz, A. (2020). Acute cigarette smoke-inducedeQTLaffects formyl peptide receptor expression and lung function. Respirology. https://doi.org/10.1111/resp.13960

Shah, P. L., & Slebos, D-J. (2020). Bronchoscopic interventions for severe emphysema: Where are we now? Respirology, 25(9), 972-980. https://doi.org/10.1111/resp.13835

Ali, M., Kim, R., Brown, A., Vanka, K., Mayall, J., Liu, G., Pillar, A., Aryal, R., Jones, B., Xenaki, D., Borghuis, T., Karim, R., Pinkerton, J., Donovan, C., Heidari, M., Martin, K., Burgess, J., Oliver, B., Trinder, D., ... Horvat, J. (2020). CRITICAL ROLE FOR IRON ACCUMULATION IN THE PATHOGENESIS OF PULMONARY FIBROSIS. Respirology, 25, 92-92.

Rathnayake, S., Vermeulen, C., Hacken, T. N., Timens, W., Kooistra, W., Heijink, H., Brandsma, C., Oliver, B., Van Den Berge, M., & Faiz, A. (2020). Longitudinal effects of 12 months smoking cessation on dna methylation and gene expression in bronchial biopsies. Respirology, 25, 30-30.

Arellano-Maric, M. P., Hamm, C., Duiverman, M. L., Schwarz, S., Callegari, J., Storre, J. H., Schmoor, C., Spielmanns, M., Galetke, W., & Windisch, W. (2020). Obesity hypoventilation syndrome treated with non-invasive ventilation: Is a switch to CPAP therapy feasible? Respirology, 25(4), 435-442. https://doi.org/10.1111/resp.13704

Park, H-S., Yoon, D., Lee, H. Y., Ban, G-Y., Wan Yau Ming, S., Jie, J. L. Z., Carter, V., Hardjojo, A., Van Boven, J. F. M., & Price, D. B. (2019). Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA. Respirology, 24(10), 972-979. https://doi.org/10.1111/resp.13559

Duiverman, M. L. (2019). Mechanism of benefit of non-invasive ventilation in COPD with hypercapnic respiratory failure - Reply. Respirology, 24(5), 494-495. https://doi.org/10.1111/resp.13523

van der Leest, S., & Duiverman, M. L. (2019). High-intensity non-invasive ventilation in stable hypercapnic COPD: Evidence of efficacy and practical advice. Respirology, 24(4), 318-328. https://doi.org/10.1111/resp.13450

Kostikas, K., Ryan, R., Fogel, R., Cao, H., Kocks, J., Agostoni, P., Rhee, C., Hurst, J., Jones, R., & Price, D. (2019). CHARACTERISTICS AND TREATMENT OF PATIENTS WITH COMORBID COPD AND HEART FAILURE. Respirology, 24, 125-125.

Kim, C., Dilokthornsakul, P., Campbell, J. D., & Van Boven, J. F. M. (2018). Development of a cost-effectiveness model to assess asthma inhaler adherence and technique interventions. Respirology, 23, 211. https://doi.org/10.1111/resp.13420

and the Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group, Hartjes, F. J., Vonk, J. M., Faiz, A., Hiemstra, P. S., Lapperre, T. S., Kerstjens, H. A. M., Postma, D. S., & van den Berge, M. (2018). Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD. Respirology, 23(11), 1023-1031. https://doi.org/10.1111/resp.13312

Hartman, J. E., Klooster, K., Groen, H., ten Hacken, N. H. T., & Slebos, D-J. (2018). Cost-effectiveness of endobronchial valve treatment in patients with severe emphysema compared to standard medical care. Respirology, 23(9), 835-841. https://doi.org/10.1111/resp.13295

Singapore International Respiratory Consortium (2018). International research collaboration: The way forward. Respirology, 23(7), 654-655. https://doi.org/10.1111/resp.13327

McKinstry, S., Pilcher, J., Bardsley, G., Berry, J., Van de Hei, S., Braithwaite, I., Fingleton, J., Weatherall, M., & Beasley, R. (2018). Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial. Respirology, 23(4), 378-384. https://doi.org/10.1111/resp.13185

Welling, J. B. A., Hartman, J. E., van Rikxoort, E. M., Ten Hacken, N. H. T., Kerstjens, H. A. M., Klooster, K., & Slebos, D-J. (2018). Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema. Respirology, 23(3), 306-310. https://doi.org/10.1111/resp.13178

Rhee, C. K., Park, H. Y., Yoo, K. H., Kim, D. K., Park, H-S., Ming, S. W. Y., van Boven, J., Ling, J. Z. J., & Price, D. (2017). CHANGING ICS/LABA THERAPY FROM DPI TO PMDI: AN OBSERVATIONAL STUDY ON ASTHMA COST OUTCOMES IN SOUTH KOREA. Respirology, 22, 96.

Lim, T. K., Ko, F. W. S., Benton, M. J., Van den Berge, M., & Mak, J. (2017). Year in review 2016: Chronic obstructive pulmonary disease and asthma. Respirology, 22(4), 820-828. https://doi.org/10.1111/resp.13037

Pouwels, S. D., Van Geffen, W. H., Jonker, M. R., Kerstjens, H. A. M., Nawijn, M. C., & Heijink, I. H. (2017). Increased neutrophil expression of pattern recognition receptors during COPD exacerbations. Respirology, 22(2), 401-404. https://doi.org/10.1111/resp.12912

Wan Yau Ming, S., Rhee, C. K., Park, H. Y., Yoo, K. H., Kim, D. K., Van Boven, J. F., Price, D., & Park, H. S. (2016). Real-life characteristics of asthma inhaler device use in South Korea. Respirology, 21, 170. [APSR6-0779]. https://doi.org/10.1111/resp.12939-15

Price, D., Park, H. S., Yoon, D., Lee, H. Y., Wan Yau Ming, S., & Van Boven, J. F. (2016). Real-life effects of switching LABA/ICS dry powder inhalers to formoterol/fluticasone in Korean asthma patients: The Transfform study. Respirology, 21, 22.

Zwerink, M., Kerstjens, H. A. M., van der Palen, J., van der Valk, P., Brusse-Keizer, M., Zielhuis, G., & Effing, T. (2016). (Cost-)effectiveness of self-treatment of exacerbations in patients with COPD: 2 years follow-up of a RCT. Respirology, 21(3), 497-503. https://doi.org/10.1111/resp.12697

Tang, F. S. M., Van Ly, D., Spann, K., Reading, P. C., Burgess, J. K., Hartl, D., Baines, K. J., & Oliver, B. G. (2016). Differential neutrophil activation in viral infections: Enhanced TLR-7/8-mediated CXCL8 release in asthma. Respirology, 21(1), 172-179. https://doi.org/10.1111/resp.12657

Farah, C. S., Keulers, L. A. B., Hardaker, K. M., Peters, M. J., Berend, N., Postma, D. S., Salome, C. M., & King, G. G. (2015). Association between peripheral airway function and neutrophilic inflammation in asthma. Respirology, 20(6), 975-981. https://doi.org/10.1111/resp.12550

Burgess, J., Munk, L., Jaffar, J., Black, J., & Oliver, B. (2015). BIBF1120 inhibits proliferation and fibulin-1 production from fibroblasts. Respirology, 20, 59. https://doi.org/10.1111/resp.12494

Tjin, G., Jegathees, T., Mahar, A., Pw Kable, E., & K Burgess, J. (2015). Lysyl Oxidases: Cause Of Collagen I Matrix Remodelling In Idiopathic Pulmonary Fibrosis? Respirology, 20(2), 88. https://doi.org/10.1111/resp.12495

Harkness, L., Ashton, A., & Burgess, J. (2015). The ECM deposited by basal asthmatic and non-asthmatic ASM cells is different in composition but not biological function. Respirology, 20, 97. https://doi.org/10.1111/resp.12495

Harkness, L. M., Ma, J. C. T., Ashton, A. W., & Burgess, J. K. (2015). IS THE RESOLVING ROLE OF TUMSTATIN ENOUGH TO COUNTERACT THE COMPLEX DYSREGULATION OF ANGIOGENESIS IN ASTHMA? Respirology, 20, 24-24.

Hartman, J. E., Klooster, K., Gortzak, K., ten Hacken, N. H. T., & Slebos, D-J. (2015). Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema. Respirology, 20(2), 319-326. https://doi.org/10.1111/resp.12435

Hartman, J. E., Slebos, D-J., Boezen, H. M., de Greef, M. H. G., Kerstjens, H. A. M., & ten Hacken, N. H. T. (2015). Selecting the increment size for a maximal incremental cycle test in patients with COPD. Respirology, 20(2), 352-355. https://doi.org/10.1111/resp.12451

Berkhof, F. F., van den Berg, J. W. K., Uil, S. M., & Kerstjens, H. A. M. (2015). Telemedicine, the effect of nurse-initiated telephone follow up, on health status and health-care utilization in COPD patients: A randomized trial. Respirology, 20(2), 279-285. https://doi.org/10.1111/resp.12437

Mineshita, M., & Slebos, D-J. (2014). Bronchoscopic interventions for chronic obstructive pulmonary disease. Respirology, 19(8), 1126-1137. https://doi.org/10.1111/resp.12362

Gompelmann, D., Eberhardt, R., Slebos, D-J., Brown, M. S., Abtin, F., Kim, H. J., Holmes-Higgin, D., Radhakrishnan, S., Herth, F. J. F., & Goldin, J. (2014). Diagnostic performance comparison of the Chartis System and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. Respirology, 19(4), 524-530. https://doi.org/10.1111/resp.12253

Kerstjens, H., Bleecker, E., Meltzer, E., Casale, T., Pizzichini, E., Schmidt, O., Engel, M., Bour, L., Bateman, E., Moroni-Zentgraf, P., & De La Hoz, A. (2014). TIOTROPIUM AS ADD-ON THERAPY TO INHALED CORTICOSTEROIDS FOR PATIENTS WITH SYMPTOMATIC ASTHMA: LUNG FUNCTION AND SAFETY. Respirology, 19, 78-78. http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=10&SID=P1Fyq7czRMOiHE9ZbQ2&page=1&doc=1

Kerstjens, H., Bleecker, E., Meltzer, E., Casale, T., Pizzichini, E., Schmidt, O., Engel, M., Bour, L., Bateman, E., Moroni-Zentgraf, P., & De La Hoz, A. (2014). TIOTROPIUM AS ADD-ON TO INHALED CORTICOSTEROIDS SIGNIFICANTLY IMPROVES ASTHMA CONTROL AS REFLECTED BY THE ACQ RESPONDER RATE. Respirology, 19, 78-78. http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=14&SID=P1Fyq7czRMOiHE9ZbQ2&page=1&doc=1

Heijink, I. H., & van den Berge, M. (2013). Are salmeterol's beneficial effects on corticosteroid action in the airways executed at the epithelial barrier? Respirology, 18(8), 1165-1166. https://doi.org/10.1111/resp.12180

Price, D., Van der Molen, T., & Fletcher, M. (2013). EXACERBATIONS AND SYMPTOMS REMAIN COMMON IN PATIENTS WITH ASTHMA CONTROL: A SURVEY OF 8000 PATIENTS IN EUROPE. Respirology, 18, 35-35.

Haghi, M., Traini, D., Postma, D. S., Bebawy, M., & Young, P. M. (2013). Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler. Respirology, 18(8), 1197-1201. https://doi.org/10.1111/resp.12146

Hashimoto, S., Engel, M., Schmidt, H., Moroni-Zentgraf, P., & Kerstjens, H. A. M. (2013). ONCE-DAILY TIOTROPIUM AS ADD-ON TO ICS+ LABA FOR PATIENTS WITH SEVERE SYMPTOMATIC ASTHMA: BASELINE CHARACTERISTICS IN JAPANESE PATIENTS. Respirology, 18(s4), 88. https://doi.org/10.1111/resp.12184_3

Ng, H. Y., Oliver, B. G. G., Burgess, J. K., Krymskaya, V. P., Black, J. L., & Moir, L. M. (2013). DOXYCYCLINE INHIBITS RHOA-GTPASE ACTIVITY IN MOUSE EMBRYONIC FIBROBLASTS. Respirology, 18, 49-49.

Keller, M., Jaffar, J., Corte, T. J., Black, J. L., Webster, S., Troy, L., Corte, P., Torzillo, P., & Burgess, J. K. (2013). FIBULIN-1 AND PERIOSTIN LEVELS ARE ASSOCIATED WITH THE SEVERITY OF FIBROTIC LUNG DISEASE. Respirology, 18, 17-17.

Fitzpatrick, M., Donovan, C., Esposito, J., Simoons, M., & Bourke, J. (2013). ROSIGLITAZONE, BUT NOT SALBUTAMOL, OPPOSES CONTRACTION TO DIVERSE AGONISTS IN SMALL AIRWAYS IN MOUSE LUNG SLICES. Respirology, 18, 40-40.

Donovan, C., Esposito, J., Simoons, M., Royce, S., Tang, M. K., & Bourke, J. E. (2013). ROSIGLITAZONE IS A SUPERIOR DILATOR THAN B2-AGONISTS UNDER INFLAMMATORY CONDITIONS IN MOUSE SMALL AIRWAYS. Respirology, 18, 25-25.

Kuo, C., Lim, S., King, N. J. C., Bartlett, N. W., Walton, R. P., Zhu, J., Glanville, N., Aniscenko, J., Johnston, S. L., Burgess, J. K., Black, J. L., & Oliver, B. G. (2011). Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo. Respirology, 16(2), 367-77. https://doi.org/10.1111/j.1440-1843.2010.01918.x

Lau, J. Y., Oliver, B. G., Moir, L. M., Black, J. L., & Burgess, J. K. (2010). Differential expression of peroxisome proliferator activated receptor gamma and cyclin D1 does not affect proliferation of asthma- and non-asthma-derived airway smooth muscle cells. Respirology, 15(2), 303-12. https://doi.org/10.1111/j.1440-1843.2009.01683.x